Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Statera

Concern as Scottish Government given different plans for hydro project to regulators

Concerns have been raised over differences in information provided to the Scottish Government and UK energy regulator regarding a planned…

The National (Scotland) · Aug 20

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Apr 28, 2022

Why Are Statera Biopharma Shares Surging Today

Statera Biopharma Inc (NASDAQ:STAB) has entered into a non-binding term sheet with Immune Therapeutics Inc (OTC:IMUN) to sell its naltrexone and met-enkephalin rights. The transaction is contingent upon the negotiation of a definitive agreement and satisfaction of several closing conditions, including a contingency on Immune Therapeutics financing. Under the anticipated terms, Statera will receive an…

Benzinga · Apr 28, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United Kingdom

151,382 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.